SELL YOUR PRODUCTS
*mymedicalexpo  
English

Medium reagent SensiScreen®
for cancersfor nucleic acidsfor PCR

medium reagent
medium reagent
Add to favorites
Compare this product

Characteristics

Type
reagent medium
Applications
for cancers, for nucleic acids, for PCR
Other characteristics
liquid

Description

CE IVD Cancer Companion Diagnostics SensiScreen® CE IVD are real-time PCR based assays for somatic mutation detection in cancer patients. SensiScreen® assays combine ultra high sensitivity with multiplexing capabilities, speed, ease-of-use and little hands-on-time. Important features of SensiScreen® assays are the implementation of PentaBase’s proprietary DNA analogue platform technology and the inclusion of baseblockers that make SensiScreen® assays superior to most current somatic mutation tests with regard to sensitivity and specificity. Features Limit of detection, LOD, of FFPE assays 0.25% – 1.5% of mutant DNA in a wild type background (5 to 50 nG gDNA input) LOD of liquid assays down to one copy of mutated DNA (up to 5 nG gDNA input) Hands-on-time 1-4 minutes per sample Time to answer < 1½ hours

Catalogs

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.